The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease.
Su, Z
The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease. [electronic resource] - European journal of immunology Mar 2001 - 947-58 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0014-2980
10.1002/1521-4141(200103)31:3<947::aid-immu947>3.0.co;2-m doi
Antigens, Viral--immunology
CD4-Positive T-Lymphocytes--immunology
Cell Line
Cells, Cultured
Cytotoxicity Tests, Immunologic
Dendritic Cells--immunology
Epstein-Barr Virus Infections--immunology
Herpesvirus 4, Human--immunology
Hodgkin Disease--immunology
Humans
Immunophenotyping
Lymphocyte Activation
T-Lymphocytes, Cytotoxic--immunology
Transfection
Viral Matrix Proteins--genetics
The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease. [electronic resource] - European journal of immunology Mar 2001 - 947-58 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0014-2980
10.1002/1521-4141(200103)31:3<947::aid-immu947>3.0.co;2-m doi
Antigens, Viral--immunology
CD4-Positive T-Lymphocytes--immunology
Cell Line
Cells, Cultured
Cytotoxicity Tests, Immunologic
Dendritic Cells--immunology
Epstein-Barr Virus Infections--immunology
Herpesvirus 4, Human--immunology
Hodgkin Disease--immunology
Humans
Immunophenotyping
Lymphocyte Activation
T-Lymphocytes, Cytotoxic--immunology
Transfection
Viral Matrix Proteins--genetics